BRGX OTC
BioRegenx, Inc.
1W: -35.8%
1M: -56.2%
3M: -54.0%
YTD: -70.8%
$0.00
-0.00 (-12.50%)
Weekly Expected Move ±38.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.4M
52W Range0.0025-0.024
Volume141,878
Avg Volume29,797
Beta-2.71
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOWilliam Resides
Employees6
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2024-05-29
Websitebioregenx.com
7407 Ziegler Road
Chattanooga, TN 37421
US
Chattanooga, TN 37421
US
866 770 4067
About BioRegenx, Inc.
BioRegenx, Inc. develops, manufactures, and sells medical test equipment, science-based nutritional products, and AI-driven health monitoring technologies. Its products include the GlycoCheck system for microvascular health assessment, the Endocalyx Pro dietary supplement, and the DocSun AI engine for contactless vital sign monitoring. The company focuses on regenerative biotherapeutics, anti-aging, and non-invasive medical and wellness devices.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Janney Richard | 0 | — | 2024-10-07 | |
| Resides William | 0 | — | 2024-03-08 | |
| Resides William | 0 | — | 2024-03-08 | |
| Resides William | 0 | — | 2024-03-08 | |
| Hennerberg Gary | 0 | — | 2024-03-08 |